{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:24:15Z","timestamp":1790501055836,"version":"4.1.0"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AR"],"published-print":{"date-parts":[[2017,9,6]]},"DOI":"10.21873\/anticanres.11912","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T17:23:45Z","timestamp":1504718625000},"source":"Crossref","is-referenced-by-count":3,"title":["Role of Caspase-9 Gene Ex5+32 G>A (rs1052576) Variant in Susceptibility to Primary Brain Tumors"],"prefix":"10.21873","volume":"37","member":"9336","container-title":["Anticancer Research"],"original-title":[],"link":[{"URL":"http:\/\/ar.iiarjournals.org\/content\/37\/9\/4997.full.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:54:27Z","timestamp":1524020067000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/content\/37\/9\/4997.abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,6]]}},"URL":"https:\/\/doi.org\/10.21873\/anticanres.11912","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"value":"0250-7005","type":"print"},{"value":"1791-7530","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]}}}